Search results for "Opportunistic Infections"

showing 10 items of 60 documents

PROBIOTICS: IN SICKNESS AND IN HEALTH

2018

Settore BIO/17 - IstologiaPROBIOTIC BACTEREMIA CANCER LACTOBACILLUS OPPORTUNISTIC INFECTIONS MICROBIOTA
researchProduct

Pneumococcal vaccination in celiac disease

2019

Introduction: Celiac disease (CD) is an immune-mediated disorder associated with gluten exposure in genetically predisposed subjects. Areas covered: Infectious disease is one of the causes of morbidity and mortality in CD patients. Invasive streptococcus pneumoniae (pneumococcus) is a particularly dangerous morbid condition in both the general population and celiac patients. Pneumococcal vaccination is the most effective means for its prevention. Expert opinion: In CD, evaluation of spleen function should be useful to select patients who may benefit from vaccination to reduce the risk of pneumococcal disease. Different strategies could be employed: physicians could search for signs of hypos…

Settore MED/09 - Medicina InternaDiseaseOpportunistic InfectionsHypersplenismPneumococcal InfectionsPneumococcal VaccinesImmunocompromised Host03 medical and health sciences0302 clinical medicineRisk FactorshyposplenismAnimalsHumansCeliac diseasepneumoniaMedicineinfectionschemistry.chemical_classificationHepatologybusiness.industryVaccinationGastroenterologynutritional and metabolic diseasesCeliac disease; hyposplenism; infections; pneumococcal vaccination; pneumoniaProtective FactorsPrognosisGluteninfectiondigestive system diseaseschemistryInfectious disease (medical specialty)030220 oncology & carcinogenesisPneumococcal vaccinationImmunology030211 gastroenterology & hepatologypneumococcal vaccinationbusinessSpleenExpert Review of Gastroenterology & Hepatology
researchProduct

Host immune response to Cryptosporidium parvum infection

2010

Species of the genus Cryptosporidium are protozoan parasites (Apicomplexa) that cause gastroenteritis in animals and humans. Of these Cryptosporidium parvum and Cryptosporidium hominis are the major causative agents of human cryptosporidiosis. Whereas infection is self-limiting in the immunocompetent hosts, immunocompromised individuals develop a chronic, life-threatening disease. As specific therapeutic or preventive interventions are not yet available, better understanding of the immune response to the parasite is required. This minireview briefly summarizes the factors involved in the innate and acquired immune response in this pathogen-host interaction with an emphasis on more recent da…

T-Lymphocytesanimal diseasesAIDS-Related Opportunistic InfectionsImmunologyAntibodies ProtozoanCryptosporidiosisAdaptive ImmunityBiologyNitric OxideImmunocompromised HostMiceImmune systemIntestinal mucosaImmunityparasitic diseasesAnimalsHumansIntestinal MucosaCryptosporidium parvumB-LymphocytesPhagocytesAIDS-Related Opportunistic InfectionsComplement System ProteinsDendritic CellsGeneral MedicineAcquired immune systembiology.organism_classificationVirologyImmunity InnateKiller Cells NaturalDisease Models AnimalInfectious DiseasesCryptosporidium parvumImmunologyCytokinesParasitologyImmunocompetenceImmunocompetenceCryptosporidium hominisExperimental Parasitology
researchProduct

Vibrio vulnificus biotype 2, pathogenic for eels, is also an opportunistic pathogen for humans

1996

We report that the eel pathogen Vibrio vulnificus biotype 2 is also an opportunistic pathogen for humans. Results from a detailed comparative study using reference strains of both biotypes revealed that the clinical strain ATCC 33817, originally isolated from a human leg wound and classified as V. vulnificus (no reference on its biotype is noted), belongs to biotype 2 of the species. As a biotype 2 strain, it is negative for indole and pathogenic for eels and mice, harbors two plasmids of high MrS, and belongs to serogroup E, recently proposed as characteristic of biotype 2 strains. In consequence, appropriate measures must be taken by consumers, particularly by those running a health risk,…

VirulenceVibrio vulnificusBiologyOpportunistic InfectionsApplied Microbiology and BiotechnologyMicrobiologyDisease OutbreaksFish DiseasesMiceVibrionaceaeVibrio InfectionsmedicineAnimalsHumansPathogenEpizooticVibrioEelsEcologyVirulenceOutbreakmedicine.diseasebiology.organism_classificationVirologyVibrioPhenotypeVibrio InfectionsFood ScienceBiotechnologyPlasmidsResearch Article
researchProduct

[Norovirus infections: an overview]

2010

National audience; Noroviruses belong to the Caliciviridae family. They are a major cause of sporadic cases and outbreaks of gastroenteritis in all age groups, and are responsible for a considerable disease burden in industrialized countries. Noroviruses are single-stranded RNA viruses, and show great genetic diversity making their detection difficult. Noroviruses can be divided into 5 genogroups, which themselves are subdivided into genotypes. Besides chance mutations that occur during viral replication, the great heterogeneity observed among noroviruses is also due to intra and inter-genotypic recombination events between strains. Some of these new variants or new recombinants are frequen…

[SDV.MP.VIR] Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRecombination GeneticCross InfectionvirusesNorovirusGenetic Variationvirus diseasesOpportunistic Infections[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/Virologydigestive system diseasesDisease OutbreaksGastroenteritisRodent DiseasesFecesImmunocompromised HostMicefluids and secretionsPolysaccharidesAnimalsHumansRNA ViralReceptors VirusReassortant VirusesCaliciviridae Infections
researchProduct

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group fo…

2000

Toxoplasmosis after hematopoietic stem transplantation. Report of a 5-year survey from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

medicine.medical_specialtyBone marrow transplantPremedicationAntibodies ProtozoanBlood DonorsOpportunistic InfectionsImmunocompromised HostSeroepidemiologic StudiesInternal medicineTrimethoprim Sulfamethoxazole Drug CombinationEpidemiologymedicineAnimalsHumansTransplantation HomologousTransplantationMarrow transplantationbusiness.industryHematopoietic Stem Cell TransplantationHematologymedicine.diseaseToxoplasmosisTransplantationHaematopoiesissurgical procedures operativeImmunologybusinessToxoplasmaDisease transmissionToxoplasmosisBone Marrow Transplantation
researchProduct

How to manage aspergillosis in non-neutropenic intensive care unit patients.

2014

Invasive aspergillosis has been mainly reported among immunocompromised patients during prolonged periods of neutropenia. Recently, however, non-neutropenic patients in the ICU population have shown an increasing risk profile for aspergillosis. Associations with chronic obstructive pulmonary disease and corticosteroid therapy have been frequently documented in this cohort. Difficulties in achieving a timely diagnosis of aspergillosis in non-neutropenic patients is related to the non-specificity of symptoms and to lower yields with microbiological tests compared to neutropenic patients. Since high mortality rates are typical of invasive aspergillosis in critically ill patients, a high level …

medicine.medical_specialtyPediatricsChronic ObstructiveAntifungal AgentsCritical IllnessPopulationPulmonary diseaseSettore MED/41 - AnestesiologiaReviewNeutropeniaOpportunistic InfectionsAspergillosisCritical Care and Intensive Care MedicineCommunicable DiseasesCommunicable Diseases Emerginglaw.inventionPulmonary DiseaseImmunocompromised HostPulmonary Disease Chronic ObstructiveAspergillosis non-neutropenic ICUlawAdrenal Cortex HormonesRisk FactorsEpidemiologymedicinenon-neutropenicPrevalenceAspergillosisHumansIntensive care medicineeducationEmergingeducation.field_of_studybusiness.industryIncidence (epidemiology)Medicine (all)IncidenceAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicinemedicine.diseasePrognosisIntensive care unitAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised HostIntensive Care UnitsCohortICUAdrenal Cortex Hormones; Antifungal Agents; Aspergillosis; Communicable Diseases Emerging; Critical Illness; Humans; Incidence; Intensive Care Units; Opportunistic Infections; Prevalence; Prognosis; Pulmonary Disease Chronic Obstructive; Risk Factors; Immunocompromised Host; Critical Care and Intensive Care Medicine; Medicine (all)businesssepsis aspergillosis icu managementCritical care (London, England)
researchProduct

VIH et noma au Burkina Faso

2012

Summary Introduction Noma is a “gangrenous” disease beginning in gums and spreading to other parts of the face. It usually occurs in undernourished children with bad orodental hygiene. Its incidence in adults is increasing. HIV infection is very common in African countries. We had for objective to compare noma characteristics in patients with, or without, HIV. Material and methods This retrospective and descriptive study included patients managed for noma in our unit from January 1988 to December 2007. The clinical, epidemiological, and outcome data of patients treated for noma were compared according to HIV infection status. Results Two hundred and twelve patients were included and 14 (6.6…

medicine.medical_specialtyPediatricsbusiness.industryOpportunistic infectionIncidence (epidemiology)AIDS-Related Opportunistic InfectionsMortality rateRetrospective cohort studymedicine.diseaseSurgeryNomaOtorhinolaryngologyEpidemiologyMedicineSurgeryOral SurgerybusinessCause of deathRevue de Stomatologie et de Chirurgie Maxillo-faciale
researchProduct

Die Lungentuberkulose – aktuelle radiologische Diagnostik einer alten Krankheit

2000

Inzidenz. Abnehmende Inzidenzen aktiver Tuberkulose in den Industrielandern haben diese Erkrankung aus dem Bewusstsein vieler verdrangt. Dennoch stellt die Tuberkulose weiterhin weltweit die am haufigsten zum Tode fuhrende Infektionskrankheit dar. In den Industrielandern tragen Faktoren wie Einwanderungsbewegungen, zunehmende Verarmung und die Zunahme immunsupprimierter Patienten, insbesondere durch die HIV-Epidemie, dazu bei, dass ein Reservoir fur die Tuberkulose aufrecht erhalten wird. Diagnose. Eine fruhzeitige Diagnose ist wegen der spezifischen Therapiemoglichkeiten entscheidend fur den Krankheitsverlauf; im Falle von multiresistenten Stammen ist sie wichtig zur Verhinderung einer wei…

medicine.medical_specialtyÜbersichtLungeReviewKey words TuberculosisSchlüsselwörter TuberkuloseDiagnostikHumansMedicineRadiology Nuclear Medicine and imagingTuberculomaTuberculin testLungDiagnosticsTuberculosis PulmonaryGynecologyAIDS-Related Opportunistic InfectionsTuberculin Testbusiness.industryChronische InfektionenSputumMycobacterium tuberculosisRadiographyLung diseaseHIV-1Lymph NodesbusinessDer Radiologe
researchProduct

The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guideline…

2010

Biological therapies are an important step in the management of Inflammatory Bowel Diseases. In consideration of high cost and safety issues there is the need to have clear recommendations for their use. Despite the American Gastroenterological Association and the European Crohn's and Colitis Organisation have published exhaustive Inflammatory Bowel Disease guidelines, national guidelines may be necessary as cultural values, economical and legal issues may differ between countries. For these reasons the Italian Society of Gastroenterology and the Italian Group for the study of Inflammatory Bowel Disease have decided to elaborate the Italian guidelines on the use of biologics in Inflammatory…

methods Tumor Necrosis Factor-alphaAnti-Inflammatory AgentsUlcerativeDiseaseGUIDELINESHumanized Antibodieetiology Pregnancy Pregnancy ComplicationGastroenterologyInflammatory bowel diseaseetiology Opportunistic InfectionCrohn DiseasePregnancyNeoplasmsMonoclonaldrug therapy Remission Inductionantagonists /&/ inhibitorsSettore MED/12 - GastroenterologiaRemission InductionGastroenterologyAntibodies MonoclonalUlcerative colitisAnti-Inflammatory AgentItalyadverse effects/therapeutic use Intestinal FistulaTumor necrosis factor alphaFemaleImmunosuppressive Agentsmedicine.drugbiological drugsmedicine.medical_specialtyIBDOpportunistic InfectionsAntibodies Monoclonal HumanizedAutoimmune Diseasesadverse effects/therapeutic use Autoimmune DiseaseInternal medicinemedicineAdalimumabIntestinal FistulaHumansColitisdiagnosis/drug therapy/surgery Italy Neoplasmadverse effects/therapeutic use AntibodieHepatologydrug therapy Female Humans Immunosuppressive Agentbusiness.industryTumor Necrosis Factor-alphaAdalimumabCancermedicine.diseaseInfliximabInfliximabdigestive system diseasesdrug therapy Crohn Diseaseetiology ColitiPregnancy ComplicationsColitis Ulcerativebusiness
researchProduct